Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: MiR-181b sensitizes glioma cells to teniposide by targeting MDM2

Figure 1

MiR-181b expression is negatively related to glioma grade. A: The expression of miR-181b is low in high-grade (Grade II to Grade IV) while high in low-grade (Grade I) gliomas (**: p < 0.01). B: The survival rate of 90 glioma patients showed that high level of miR-181b is a good prognostic marker for longer survival (p < 0.05).

Back to article page